GABA Signaling and Neuroactive Steroids in Adrenal Medullary Chromaffin Cells
- 1Department of Cell and Systems Physiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Japan
- 2Department of Physiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Japan
- 3Department of Genetic and Behavioral Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Japan
Gamma-aminobutyric acid (GABA) is produced not only in the brain, but also in endocrine cells by the two isoforms of glutamic acid decarboxylase (GAD), GAD65 and GAD67. In rat adrenal medullary chromaffin cells only GAD67 is expressed, and GABA is stored in large dense core vesicles (LDCVs), but not synaptic-like microvesicles (SLMVs). The α3β2/3γ2 complex represents the majority of GABAA receptors expressed in rat and guinea pig chromaffin cells, whereas PC12 cells, an immortalized rat chromaffin cell line, express the α1 subunit as well as the α3. The expression of α3, but not α1, in PC12 cells is enhanced by glucocorticoid activity, which may be mediated by both the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). GABA has two actions mediated by GABAA receptors in chromaffin cells: it induces catecholamine secretion by itself and produces an inhibition of synaptically evoked secretion by a shunt effect. Allopregnanolone, a neuroactive steroid which is secreted from the adrenal cortex, produces a marked facilitation of GABAA receptor channel activity. Since there are no GABAergic nerve fibers in the adrenal medulla, GABA may function as a para/autocrine factor in the chromaffin cells. This function of GABA may be facilitated by expression of the immature isoforms of GAD and GABAA receptors and the lack of expression of plasma membrane GABA transporters (GATs). In this review, we will consider how the para/autocrine function of GABA is achieved, focusing on the structural and molecular mechanisms for GABA signaling.
GABA is synthesized not only in the brain, but also in peripheral tissues and organs, such as the pancreas (Okada et al., 1976) and the adrenal medulla. The presence of GABA in the bovine adrenal medulla was first reported in 1984 (Kataoka et al., 1984), and thereafter GABA’s actions in adrenal medullary chromaffin cells of dogs (Kataoka et al., 1986), cattle (Peters et al., 1989), rats (Matsuoka et al., 2008), and guinea pigs (Inoue et al., 2013) in vivo and/or in vitro have been functionally explored.
Compared to the adrenal medulla, there is ample research on GABA in the brain where it is the major inhibitory neurotransmitter. This review is focused on the functions of GABA in the adrenal chromaffin cells, but a brief recapitulation of GABA signaling in the brain will help our understanding of GABA functions in the adrenal medulla. Neuronal GABA is synthesized from glutamic acid by glutamic acid decarboxylase (GAD), an enzyme that is encoded by two different genes, GAD2 (GAD65) and GAD1 (GAD67; Obata, 2013). GAD exists as a homo- or heterodimer of GAD65 and GAD67. GAD65 is mainly present in the nerve terminal, whereas GAD67 is diffusely distributed in the cell body as well as nerve terminals (Pinal and Tobin, 1998; Soghomonian and Martin, 1998; Obata, 2013). GAD67 plays the major role for GABA production in the embryonic brain (Asada et al., 1997), whereas the contribution of GAD65 begins to increase after birth. In the adult 50–70% of the total GABA in the brain is produced by GAD65 and the remaining GABA by GAD67 (Stork et al., 2000). Thus, both isoforms are involved in production of GABA in adult brain (Pinal and Tobin, 1998; Obata, 2013). The development of GAD65 appears to parallel that of inhibitory neuronal transmission in the brain (Greif et al., 1992). The subtypes of GABAA receptors also change during the brain development (Laurie et al., 1992; Ortinski et al., 2004). These results suggest that the function of GABA in the embryonic brain differs from its role as a neurotransmitter in the mature brain (Ben-Ari et al., 2007; Pallotto and Deprez, 2014). Thus, it is likely that GABAergic transmission has multiple functions which may change during brain development. However, how the expression of GABA signaling molecules coordinately changes remains to be fully elucidated (Succol et al., 2012).
In this review, we will consider the functions of GABA in the adrenal medulla while referring to GABA signaling in neurons and other endocrine cells. Special focus will be placed on the structural and molecular mechanisms for GABA actions in chromaffin cells. Overall the data indicate that the expression of GABA signaling molecules in adrenal chromaffin cells is finely tuned for GABA to function as a para/autocrine factor to modulate catecholamine secretion.
Morphology of GABA Signaling in the Adrenal Medulla
Localization of GABA
When the localization of GABA was examined in bovine, dog and mouse adrenal medullae with immune-labeling approaches, GAD- and/or GABA-like immunoreactivities (IRs) were detected in chromaffin cells and nerve fiber-like structures (Kataoka et al., 1984, 1986; Iwasa et al., 1998). Previously, retrograde tracing had revealed that several areas in the brain and the spinal cord had materials that were retrogradely transported from the rat adrenal medulla (Mohamed et al., 1988; Coupland et al., 1989). Thus, it is possible that neurons in such areas send GABAergic nerve fibers to adrenal chromaffin cells. However, this idea has not been supported by pharmacological analyses of neuronal transmission. Fast synaptic currents evoked in slices of the rat adrenal medulla by field stimulation were completely suppressed by application of hexamethonium, a nicotinic ACh receptor blocker (Barbara and Takeda, 1996; Kajiwara et al., 1997). These electrophysiological findings would negate the possible innervation by GABAergic fibers in the adrenal medulla. This notion is further supported by immunostaining for GAD and vesicular GABA transporter (VGAT), which is involved in the uptake of GABA into vesicles. GAD proteins were recognized in the rat adrenal medulla by immunoblotting, and GAD-like IR was present in rat adrenal chromaffin cells but not in fiber-like structures (Figure 1). Furthermore, the mRNA for GAD67, but not GAD65, was detected in rat adrenal medullae by RT-PCR analysis (Matsuoka et al., 2008; Inoue et al., 2010), suggesting that the GAD activity was not in nerve terminals. VGAT was also detected in rat adrenal chromaffin cells at the mRNA and protein levels (Matsuoka et al., 2008). The immunostaining for GAD and VGAT unambiguously indicate that GABA is synthesized in chromaffin cells, but not nerve fibers, in the adrenal medulla of at least rats.
Figure 1. Immunostaining for glutamic acid decarboxylase (GAD) and vesicular GABA transporter (VGAT) in rat adrenal medullary chromaffin cells. (A) Immunohistochemistry for GAD in rat adrenal gland. Sections were incubated overnight in PBS with (GAD) or without (PBS) rabbit anti-GAD antibody (Ab). The bound Ab was detected with the indirect immunoperoxidase method. The middle panel represents an enlargement of the area indicated by the square in the left panel. (B) Immunocytochemistry for VGAT in a dissociated rat adrenal medullary cell. The adrenal medulla was treated with collagenase and then cells were mechanically dissociated with needles. The cells were treated overnight with rabbit anti-VGAT Ab and goat anti-chromogranin A (CgA) Ab and then with secondary Abs conjugated with Alexa 488 and Alexa 546. Images from left to right represent differential interference contrast (DIC), rhodamine-like, FITC-like, and merge of the second and the third. (A,B) Are reproduced from Matsuoka et al. (2008).
GABA-Storing Secretory Vesicles
Chromaffin cells have two kinds of secretory vesicles: one is the large dense core vesicles (LDCVs) or chromaffin granules with a mean diameter of 356 nm (Plattner et al., 1997), where catecholamines are stored together with chromogranins and ATP. The second is synaptic-like microvesicles (SLMVs) with a mean diameter of 90 nm (Plattner et al., 1997), which correspond to synaptic vesicles in the nerve terminal (Thomas-Reetz and De Camilli, 1994). There is morphological and biochemical evidence that GABA is stored in LDCVs, but not in SLMVs, in rat and bovine adrenal chromaffin cells (Inoue et al., 2010). First, VGAT was co-localized with chromogranin, a marker protein of LDCVs (Figure 1B), but not synaptophysin, an integral protein of SLMVs (Navone et al., 1986). Also, fractionation analysis of homogenates of the bovine adrenal medulla revealed that VGAT was detected in the fractions of high density, where dopamine β-hydroxylase, an enzyme involved in the synthesis of noradrenaline from dopamine, was enriched, whereas synaptophysin was enriched in fractions of intermediate density (Harada et al., 2010). When the homogenate was centrifuged and divided into supernatent and pellet fractions and then the pellet was subjected to sucrose density fractionation, GABA was recovered together with catecholamines in high density fractions. Furthermore, when a fusion protein of green fluorescent protein with VGAT (GFP-VGAT) was exogenously expressed in the PC12 cell, an immortalized cell line of rat adrenal chromaffin cells, it was localized in organelles immunopositive for chromogranin. In contrast, a GFP-vesicular acetylcholine transporter fusion protein (GFP-VAChT) was mainly present in organelles that were immunopositive for synaptophysin, suggesting that GFP-VGAT and GFP-VAChT were located in LDCVs and SLMVs, respectively (Harada et al., 2010).
The two kinds of secretory vesicles also occur in pancreatic β cells (Reetz et al., 1991) where insulin and GABA are produced. Insulin is stored in LDCVs. In contrast to chromaffin cells, GABA is stored in both SLMVs and in LDCVs in β cells of at least rats (Reetz et al., 1991; Gammelsaeter et al., 2004): gold particles for GABA and VGAT were concentrated much more in SLMVs rather than in LDCVs.
Functions of LDCVs and SLMVs
Whether GABA is stored in LDCV or SLMV is important for its physiological role. Secretion mediated by SLMVs occurs rapidly compared with that of LDCVs (Kasai, 1999), for example in PC12 cells the time constants for exocytosis differ by 10× or more between SLMVs and LDCVs. This difference between SLMVs and LDCVs may be accounted for by the synaptotagmin isoforms mainly present in these two vesicles. The Ca2+ sensitivity and kinetics of Ca2+ interaction of synptotagmin differ among isoforms: Ca2+ affinity of synaptotagmin 7 is much higher than that of synaptotagmin 1 (Wang et al., 2005), and the kinetics of the former is slower than that of the latter (Hui et al., 2005). Thus, the presence of synptotagmin 1 as the main isoform in synaptic vesicles in the nerve terminal (Geppert et al., 1994) would allow action potentials arriving in the nerve terminal to trigger a rapid secretion of neurotransmitters, so that neurotransmission can occur with a delay of less than 1 ms (Johnston and Wu, 1995; Minneci et al., 2011). As in other secretory cells, the main isoforms of synaptotagmins present in LDCV and SLMV in chromaffin cells are different. The major isoform present in LDCVs is synptotagmin 7, whereas that in SLMVs is synptotagmin 1 although synaptotagmin 1 is found in LDCV (Matsuoka et al., 2011).
As mentioned previously, a part of the GABA molecules in pancreatic β cells are likely stored in SLMVs, and GABA has been shown to inhibit glucagon secretion from pancreatic α cells (Rorsman et al., 1989; Xu et al., 2006). This GABA-mediated inhibition of glucagon secretion may occur under conditions where β cells are strongly excited, so that synaptotagmin 1 in SLMVs is activated with the consequent release of GABA. That is, in the islets of Langerhans GABA released from β cells may act in a paracrine manner to reduce glucagon release from α cells. In contrast to β cells, in chromaffin cells GABA is stored in LDCV rather than SLMV. The storage of GABA in LDCVs suggests that GABA plays a modulatory role for secretion of catecholamines. As the amount of secreted catecholamine increases, that of GABA also increases and so acts to reduce high levels of secretion (see “Dual Action of GABA” Section below).
GABAA Receptors in Chromaffin Cells
Receptors for GABA comprise ionotropic GABAA receptors containing a directly-gated ion channel and metabotropic GABAB receptors (Inoue et al., 1985). Bovine chromaffin cells in culture have been shown to express GABAB receptors by functional analyses (Castro et al., 1989). However, rat chromaffin cells failed to respond to baclofen, a GABAB receptor agonist, and GABA-induced currents were suppressed by bicuculline, a GABAA receptor antagonist (Matsuoka et al., 2008), indicating the expression of GABAA receptors, but not GABAB receptors. Therefore, only GABAA receptors will be discussed here.
Subunit Composition of GABAA Receptors
GABAA receptors are a pentamer of α (α1 to α6) and β (β1 to β3) subunits, with one or more γ (γ1 to γ3), ρ (ρ1 to ρ3), δ, ɛ, or θ subunits. The possible combinations of these subunits are enormous, but the actual isoforms of GABAA receptors present in the brain are limited (Rudolph and Knoflach, 2011): 60% of them are the complex of two α1, two β, and one γ2 subunits, and in 20% of GABAA receptors, two molecules of the α2, α3, or α5 subtype are combined with two β and one γ2 subunits. In the brain, GABAA receptor expression begins early in development (Serafini et al., 1998; Ben-Ari et al., 2007), and their subunit combination changes during development (Laurie et al., 1992; Ortinski et al., 2004). The α2 and α3 subunits are predominantly expressed in the embryonic rat brain, while the α1 subunit becomes predominant during the first 3 weeks of postnatal life (Okada et al., 2000; Bosman et al., 2002; Ehrlich et al., 2013). Because of this developmental change, α2 and α3 are called immature subunits, whereas α1 is a mature subunit. The replacement of α2 or α3 subunits with α1 results in a shortening of the time course of the decay of inhibitory postsynaptic currents, probably because the open time of α1-containing GABAA receptors is shorter than that of α3-containing receptors (Mozrzymas et al., 2007). Thus, this replacement leads to increased temporal precision of inhibitory neurotransmission in the brain. It has been suggested that in the embryonic brain GABAergic transmission functions in a more general, volume transmission mode that converts to a more precise, synaptic mode with development (Represa and Ben-Ari, 2005).
In contrast to the mature brain, GABA in the adrenal medulla is not involved in synaptic neurotransmission. The combination of subunits in chromaffin cells may reflect the physiological function which GABA mediates. RT-PCR and immunoblotting of rat adrenal medullae revealed the expression of α1 and α3 subunits (Matsuoka et al., 2008). With immunoprecipitation these subunits were confirmed to be complexed with β2/3 and γ2 or δ subunits. However, a recent quantitative analysis of protein expression revealed that the α3 subunit is the major α subunit expressed in adrenal medullae of not only rats, but also guinea pigs (Inoue et al., 2013). The enhancement of GABA-induced currents by L-838, 417, an α3-selective benzodiazepine analog, in guinea-pig chromaffin cells supports the dominant expression of α3 and indicates that the α3 subunit is mainly complexed with γ2 (Inoue et al., 2013). Furthermore, GABA-induced currents were suppressed by Zn2+ in a dose-dependent manner and the inhibition was well described by a rectangular hyperbola, suggesting that GABAA receptors in chromaffin cells are homogeneous (Inoue et al., 2013). To summarize, GABAA receptors in chromaffin cells are mainly represented by the α3β2/3γ2 complex.
Regulation of GABAA Receptor Expression
The fact that the α3β2/3γ2 complex constitutes the majority of GABAA receptors means chromaffin cells continue to express immature GABAA receptors in adulthood, which raises a question about how the control of subunit expression may differ between adrenal gland and brain. The internal environment drastically changes in the growth process from the prenatal period to the neonate and then juvenile periods. One such change in rats is a decrease in blood glucocorticoid during the first 2 weeks of life (Sapolsky and Meaney, 1986). Early life experience, including impaired maternal care, influences brain development and the expression of GABAA receptors in the adulthood (Caldji et al., 1998, 2003), and the blood glucocorticoid concentration increases in rats subjected to maternal deprivation (Chen et al., 2012). These observations suggest that glucocorticoids play an important role for regulation of GABAA receptors. To examine the effects of glucocorticoids on the expression of GABAA receptors, PC12 cells were used. PC12 cells were found to express α1 as well as α3 subunits, which were mainly present at the cell periphery (Inoue et al., 2013). The expression of both subunits was abolished by removal of serum from the culture medium, but that of α3—but not α1—was restored by addition of the synthetic glucocorticoid dexamethasone (Figure 2), indicating that glucocorticoid activity supports α3 expression. There are two kinds of receptors in the cytosol to which glucocorticoids bind: one is mineralocorticoid receptor (MR); the other is glucocorticoid receptor (GR; de Kloet et al., 2005). The GR and MR function either as a homodimer or heterodimer, and the affinity of MR for cortical steroids is 10-fold higher than that of GR (de Kloet et al., 2005). The expression of α3, but not α1, in PC12 cells was suppressed in a dose-dependent manner by not only mifepristone (Inoue et al., 2013), a specific GR inhibitor (Reul et al., 1990), but also by RU28318 (unpublished observations by KH and MI), a specific MR inhibitor (Ulmann et al., 1985), suggesting the involvement of MR as well as GR. In fact, the expression of MR in PC12 cells has been reported (Goto et al., 2009). Whether MR is involved in the regulation of α3 expression in adrenal chromaffin cells or not remains to be explored. One critical difference between adrenal medulla and brain may be the existence of a higher glucocorticoid level in the extracellular space of adrenal medulla (Wurtman, 2002). Thus, based on the fingdings in PC12 cells, glucocorticoids likely preserve α3 expression in adrenal chromaffin cells. Recently, a decrease in intracellular Cl− concentration ([Cl−]i) has been shown to be involved in the substitution of α1 for α3 (Succol et al., 2012). The value of [Cl−]i in neurons is determined by a balance between Na+, K+, Cl−-cotransporter type 1 (NKCC1) and K+, Cl−-cotransporter type 2 (KCC2), which are responsible for import and export of Cl−, respectively (Kaila et al., 2014). Aldosterone has been reported to enhance NKCC1 activity in vascular smooth muscle cells (Ding et al., 2014) with the consequent increase in [Cl−]i (Davis et al., 1993). These results raise the possibility that glucocorticoids enhance NKCC1 activity in chromaffin cells, thereby preserving α3-containing GABAA receptors. A further study will be required to elucidate the molecular mechanism for α3 preservation in chromaffin cells.
Figure 2. Enhancement of expression of the GABAA α3 subunit in PC12 cells by dexamethasone. (A,B) Immunofluorescent staining for α1 and α3 subunits in PC12 cells, respectively. Cells were cultured for 1 week in Dulbecco’s modified medium supplemented with 10% fetal bovine serum (FBS; control), Dulbecco’s modified medium with 10 μM dexamethasone (+DM), or Dulbecco’s modified medium (−FBS). Left and right images represent confocal fluorescent images and merge of fluorescent and DIC images. (C,D) Summaries of α1- and α3-like immunoreactivities, respectively. The amounts of α1- and α3-like immunoreactivities were measured by using ImageJ software (NIH, Bethesda, MD, USA). The amounts of the immunoreactivities in PC12 cells cultured with DM (+DM) and without DM and FBS (−FBS) were expressed as percentages of those in the control PC12 cells, which were measured under the same conditions. The data indicate mean ± SEM (C, n = 12, 12, and 10 for control, +DM, and −FBS, respectively; D, n = 19, 9, and 10 for control, +DM, and −FBS, respectively). #and ##represent statistical significance of P < 0.01 and P < 0.001, respectively. (B,D) Are reproduced from Inoue et al. (2013).
Effects of GABA
Differences Among Species
The fact that the expression of α3 depends on glucocorticoid activity in PC12 cells indicates that the subunit composition and/or expression of GABAA receptors in cells can be altered in culture. One of the advantages of using acutely dissociated chromaffin cells is that receptors and ion channels in cells can be examined under more physiological conditions compared with cultured cells. The responses of acutely dissociated chromaffin cells to GABA conspicuously differ between rats and guinea pigs. Application of 30 μM GABA evoked inward currents in 33% of rat chromaffin cells examined (Warashina and Inoue, 2012), but in 100% of guinea-pig chromaffin cells (Warashina and Inoue, 2012). In addition, even in responding cells the amplitudes of GABA-induced currents in rat cells were tiny compared with those in guinea-pigs. Such differences, however, did not occur for nicotine-induced currents. Since the dose response relationship for GABA did not differ noticeably between rat (Matsuoka et al., 2008) and guinea-pig chromaffin cells (Inoue et al., 2013), the subunit composition of GABAA receptors in both may be the same, suggesting that the difference in amplitude is the result of different levels of expression. There is a possibility that the difference in the expression level of GABAA receptors is related to the humoral environments in rats and guinea pigs. One difference is that the main glucocorticoid in rats and mice is corticosterone, whereas that in guinea pigs and humans is cortisol. The glucocorticoid activity of corticosterone is one-tenth to one-third that of cortisol (Mahgoub et al., 1997). Therefore, corticosterone may not be sufficient to maintain a high level of expression of α3-containing GABAA receptors in rat adrenal chromaffin cells.
Dual Action of GABA
The fact that GABA induces excitation in adrenal chromaffin cells with the consequent secretion of catecholamines has been known since the 1980s. As GABA did not change the percentage of adrenaline in the total catecholamine secreted in perfused rat adrenal glands (Inoue et al., 2010), GABAA receptors are likely to be expressed similarly in adrenaline and noradrenaline cells. This non-selectivity is in contrast with the selective expression of M1 muscarinic receptors in adrenaline cells, a muscarinic receptor subtype involved in secretion (Inoue et al., 2010; Harada et al., 2015).
The intracellular concentration of Cl− in rat chromaffin cells was electrophysiologically estimated to be 31 mM, as the equilibrium potential for Cl− ([ECl]) is -38 mV (Matsuoka et al., 2008; Inoue et al., 2010). It is likely that the chloride gradient and ECl in rat chromaffin cells is determined by finely tuned expression and/or function of NKCC1 and KCC2 (Kaila et al., 2014). This value of ECl may allow GABA to have a dual action; GABA by itself induces excitation, but inhibits the much larger excitation resulting from a volley of neuronal inputs. As shown in Figure 3, GABA alone induced a depolarization with the consequent activation of voltage-dependent Ca2+ channels by stimulating GABAA receptors, resulting in catecholamine secretion. When the adrenal medulla was electrically stimulated at a high frequency (5–10 Hz) during GABAA receptor stimulation, the total amplitude of Ca2+ signals, which consisted of GABA-induced and synaptically evoked Ca2+ responses, was smaller than that evoked synaptically alone (Figure 3). This decrease in the overall Ca2+ signal is ascribed to the fact that the membrane electrical shunt induced by GABA (reversal potential at about −38 mV) reduces the depolarization resulting from nerve stimulation and so reduces Ca2+ channel activation.
Figure 3. Suppression of the synaptically evoked Ca2+ signal in rat adrenal chromaffin cells by GABA. (A) Confocal images of Fluo-4 fluorescence in rat adrenal medulla. The adrenal gland was retrogradely loaded with Fluo-4 AM, a Ca2+ indicator via the adrenal vein, and then part of the adrenal cortex covering the medulla was removed by microscissors under a stereoscope (Warashina and Inoue, 2012). The adrenal gland was placed between a pair of silver circles for electrical stimulation. Confocal images of FITC-like fluorescence in adrenal chromaffin cells were acquired every 5 s. (B) Relative values of the change in fluorescence intensity are plotted against time. The adrenal gland was retrogradely perfused with saline via the adrenal vein, and 30 μM GABA was added to the perfusion solution during the indicated period (dotted line). Nerve fibers were electrically stimulated with 60 V pulses of 1.5 ms duration at 10 Hz for 30 s (bars). Fluorescence intensities in the areas (x and y) indicated in (A) part c were measured and presented as filled (x) and open (y) symbols, respectively. Note that the cells in the region indicated by y showed no response to the application of GABA, whereas those in the region marked x did. After correction for the decline due to photobleaching, the increase in fluorescence intensity was expressed as a fraction of the resting level. The images marked a, b, and c in (A) correspond to the points labeled in (B). (A,B) Are reproduced from Matsuoka et al. (2008).
The ECl in rat chromaffin cells is more negative than the ECl (−28 mV) in cultured bovine chromaffin cells (Xie et al., 2003). This difference might account for the apparent absence of a shunt effect of GABAA receptor activation in bovine chromaffin cells: the peak amplitude of nicotine-induced Ca2+ signals was not altered by GABAA receptor stimulation, even though GABA alone induced an increase in Ca2+ concentration (Xie et al., 2003). This failure of GABA to suppress the Ca2+ signal may be due to the ECl of −28 mV, which is likely enough to activate a substantial number of voltage-dependent Ca2+ channels. This more positive value of ECl in bovine chromaffin cells might be due to the maintenance of cells under culture conditions for a few days, which may preferentially facilitate the expression of NKCC1 rather than KCC2 with the consequent increase in [Cl−]i.
A possible dual action of GABA in adrenal chromaffin cells could have a significant physiological function. When the live organism is subjected to a stressor, the organism would respond to it with a rapid, nerve evoked secretion of catecholamines from the adrenal medulla, which results in increases in blood glucose and blood flow in the skeletal muscle. However, if a high glucose level is sustained, it would be harmful to the body, resulting in the outbreak or exacerbation of the metabolic syndrome. On the other hand, a low level of blood adrenaline would be beneficial in that it ameliorates the metabolic syndrome by facilitating glucose uptake with the consequent decrease in blood glucose (Ziegler et al., 2012). In this manner, the dual action of GABA might both enhance low levels of release and dampen high levels, and so would contribute to a delicate regulation of catecholamine secretion.
Actions of Neuroactive Steroids
Neuroactive steroids, such as allopregnanolone, are produced in adrenal glands of mammals including rats (Corpéchot et al., 1993) and humans (Genazzani et al., 1998) and are known to act on GABAA receptors (Zhu and Vicini, 1997; Belelli and Lambert, 2005). Therefore, to elucidate the function of GABA signaling in the adrenal medulla, it will be important to take into account the effects of neuroactive steroids. Figure 4 illustrates the biosynthetic pathway for adrenal steroids, in which positive (Lambert et al., 1995; Reddy and Rogawski, 2002) and negative (Park-Chung et al., 1999) allosteric modulators are denoted by single and double asterisks, respectively. The adrenal cortex of rats and mice lacks the expression of P450c17 (Le Goascogne et al., 1991; Figure 4). Therefore, the main glucocorticoid in such rodents is corticosterone, whereas in other mammals including humans it is cortisol. The lack of P450c17 results in a loss in production of dehydroepiandrosterone (DHEA) and its sulfated form or DHEAS in the adrenal cortex. In rat gonads where P450c17 is expressed, DHEAS is produced. In contrast, allopregnanolone (THP in Figure 4) is produced in the adrenal glands of rats (Corpéchot et al., 1993) and humans (Genazzani et al., 1998). It is synthesized in two steps from progesterone. 5α-reductase, which was immunologically detected in the zona fasciculata of rat adrenal glands (Yokoi et al., 1998), catalyzes the conversion from progesterone to 3α-hydroprogesterone (DHP), which is further converted to allopregnanolone by 3α-hydrosterone dehydrogenase.
Figure 4. Biosynthetic pathway of adrenal steroids. The enzymes shown mediate the conversion of steroids in the indicated step(s). The names of steroids are abbreviated: THP, 3α, 5α-tetrahydroprogesterone or allopregnanolone; DHP, 5α-dihydroprogesterone; THDOC, 3α, 5α-tetrahydrodeoxycorticosterone; DHDOC, 5α-dehydrodeoxycorticosterone; DHC, dehydrocorticosterone; DOC, 11-deoxycorticosterone; 17-OH preg, 17-OH pregnenolone; 17-OH prog, 17-OH progesterone; DHEA, dehydroepiandrosterone; DHEAS, DHEA sulfate. 3αHSD, 3α-hydroxysteroid dehydrogenase. The steroids marked by single and double asterisks are positive and negative allosteric modulators of GABAA receptors, respectively.
Exposure of guinea-pig adrenal chromaffin cells to allopregnanolone resulted in an enhancement of GABAA receptor channel activity (Inoue et al., 2013). In the presence of 0.01 and 0.1 μM allopregnanolone, the amplitude of currents induced by 3 μM GABA increased by 1.1 and 20-fold (Figure 5A). In addition, the dose-response curve for steady-state GABA-induced currents was shifted toward the left and the EC50 decreased by 24-fold in 0.1 μM allopregnanolone (from 7.2 μM to 0.3 μM; Figure 5B). This result indicates that 0.1 μM GABA, which does not induce any channel activity in the absence of allopregnanolone, is able to produce a sustained current in the presence of 0.1 μM allopregnanolone. The blood concentration of GABA in humans is about 0.1 μM (Petty, 1994), but the concentration of GABA in the extracellular space of the adrenal medulla is not known. Since GABA is thought to be released from chromaffin cells (Kataoka et al., 1984), the concentration of GABA in the vicinity of chromaffin cells is expected to be larger than the 0.1 μM concentration observed in the blood. The plasma concentration of allopregnanolone in rats has been reported to be a few nanomolar levels at rest and to be elevated to 20 nM in stress, such as swimming (Purdy et al., 1991). However, the adrenal vein drains the venous blood from the adrenal cortex through the medulla and so it is very likely that the concentration of allopregnanolone (synthesized in the cortex) will be elevated over that in the general circulation. In light of the concentrations at which the GABAA receptor channel activity in chromaffin cells is enhanced, allopregnanolone may play an important role in modulating the para/autocrine function of GABA in adrenal medullae.
Figure 5. Enhancement of GABAA receptor channel activity by allopregnanolone. (A) Whole-cell currents recorded from a dissociated guinea-pig chromaffin cell at −60 mV. The traces were obtained from the same cell. GABA at 3 or 10 μM was bath applied during the indicated period (bars) in the absence and presence of 0.01 or 0.1 μM allopregnanolone (interrupted lines). (B) Dose-response curves for GABA-induced currents at the plateau level in the absence (•) and presence (▴) of 0.1 μM allopregnanolone. The lines show fits of logistic equations with IMaxs of 1.38 and 1.31, slope factors of 2.88 and 2.83, and EC50s of 7.2 and 0.3 μM in the absence and presence of allopregnanolone, respectively. Plateau amplitudes of GABA-induced currents are expressed as fractions of those of 10 μM GABA currents in the same cells. The data represent mean ± SEM. (A,B) Are reproduced from Inoue et al. (2013).
As explained above, DHEAS is not produced in the rat adrenal cortex and its plasma concentration is at nanomolar levels (Cutler et al., 1978). On the other hand, it is a major steroid in the human adrenal cortex and its plasma concentration is 1–10 μM (Dhatariya and Nair, 2003). Therefore, DHEAS possibly has a modulatory effect on GABA signaling in the adrenal medulla of at least humans. An electrophysiological analysis of the effects of DHEAS on GABAA receptor channels in rat pituitary glands revealed that DHEAS inhibits channel activity by acting at two different sites: one is a high apparent affinity of 0.2 nM and the other is a low apparent affinity of 15 μM (Hansen et al., 1999). In guinea-pig chromaffin cells, bath application of DHEAS inhibited GABAA receptor channels in a reversible manner (unpublished observations by MI). The dose-dependent inhibition by DHEAS was well fitted with an inhibition curve with an IC50 of 3 μM and a Hill’s coefficient of 1. This low potency of inhibition would negate the possible regulation of GABA signaling in the rat adrenal medulla by DHEAS. However, it might be involved in the regulation of GABA function in the human adrenal medulla.
Concluding Remarks and Perspective
In many respects GABAergic transmission in the rat adrenal medulla resembles that in the developing brain. GABA is believed to be involved in the maturation process of the brain in the embryonic period, including proliferation of neurons, their trafficking, and synaptogenesis (Represa and Ben-Ari, 2005). These effects of GABA are mediated by GABAA receptor-mediated depolarization and the subsequent activation of voltage-dependent Ca2+ channels. GABAA receptor α subunits are divided into immature (α2 and α3) and mature (α1) types; the α2 and α3 subunits are predominantly expressed in the embryonic brain and the α3 in adult chromaffin cells. A similar distinction is noted in GADs involved in GABA synthesis. GAD67 (immature isoform) is expressed at an early stage in brain development and in adult chromaffin cells, while GAD65 (mature isoform) expression increases in the brain during synaptogenesis. GAD65 is physically associated via palmitoylation with synaptic vesicles in the nerve terminal (Kanaani et al., 2004), whereas GAD67 is diffusely present not only in the nerve terminal, but also in the cell body. It has been suggested that in the embryonic brain GABAergic transmission, which occurs in vesicular and non-vesicular manners (Cellot and Cherubini, 2013), functions in a more general, volume transmission mode that converts to a more precise, synaptic mode with development (Represa and Ben-Ari, 2005). In adult chromaffin cells there is no evidence for GABAergic synapses, and the isoforms for GAD and the GABAA receptor α subunit expressed in chromaffin cells are the immature forms. Finally, the lack of expression of plasma membrane GABA transporters (GATs; Matsuoka et al., 2008) in the adrenal gland, which are expressed in nerve terminals and glia to remove GABA from the synaptic cleft in the brain (Dalby, 2003) would enhance the ability of GABA to spread through the extracellular space. These considerations suggest that in the adrenal medulla GABA plays a para/autocrine role: it is released by chromaffin cells and acts on the same or neighboring cells to modulate catecholamine release. At least in the rat adrenal gland GABA plays a dual role. When GABA alone is applied it results in release of catecholamines. However, due to the membrane shunting effect of the chloride conductance, GABA also serves to reduce the large release elicited by volleys of nerve impulses.
GABAergic modulation of catecholamine release is also under a second level of control by adrenal cortical cells (Figure 6). The intra-adrenal portal vascular system (Coupland, 1975) drains the cortex that secretes steroid hormones including glucocorticoids and allopregnanolone. The portal system then enters the medulla, where chromaffin cells will be exposed to the secreted hormones at high concentrations (Wurtman, 2002). Hence, increased steroid release in response to stress or other stimuli will affect GABAergic modulation of catecholamine release; glucocorticoids by possibly enhancing the expression of GABAA α3 subunit and allopregnanolone by directly potentiating responses of GABAA receptor to low concentrations of GABA. Both of these actions would enhance the ability of low levels of GABA to induce release of catecholamines. However, they would also increase the ability of GABA to reduce release induced by high frequency nerve stimulation. These effects would integrate activation of the cortical cells (perhaps reflecting stress levels) with rapid effects of released catecholamines.
Figure 6. Summary of effects of adrenal cortical hormones on GABA signaling. The left image represents hematoxylin-eosin staining of mouse adrenal gland. GABA is stored in large dense core vesicles (LDCVs) or chromaffin granules in chromaffn cells. Glucocorticoids produce an increase in expression of α3-containing GABAA receptors whereas allopregnanolone produces facilitation of GABAA receptor Cl− channel activity.
The next challenge is to elucidate how the function and expression of these GABA signaling molecules are regulated to accomplish the para/autocrine function of GABA in adrenal chromaffin cells. Since adrenal chromaffin cells are exposed to adrenal cortical hormones at high concentrations through the intra-adrenal portal vascular system (Coupland, 1975), adrenal cortical hormones, such as glucocorticoids, are a first target to be investigated for their role involved in regulation and/or expression of the signaling molecules.
MI, KH, and YY had conception of research; KH, HM, HF, YU, YY, and MI performed experiments; KH and MI analyzed data; MI wrote the manuscript; All the authors approved the final version of the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This study was supported by grants from Japan Society for the Promotion of Science and The Salt Science Research Foundation. We are grateful to Dr. J. H. Steinbach (Washington University, USA) for critical comments on the manuscript and Dr. T. Nakashima for hematoxylin-eosin staining of mouse adrenal gland. Thanks are also due to T. Hatama and K. Tashiro for technical assistance.
Asada, H., Kawamura, Y., Maruyama, K., Kume, H., Ding, R. G., Kanbara, N., et al. (1997). Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U S A 94, 6496–6499. doi: 10.1073/pnas.94.12.6496
Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R., and Khazipov, R. (2007). GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol. Rev. 87, 1215–1284. doi: 10.1152/physrev.00017.2006
Bosman, L. W., Rosahl, T. W., and Brussaard, A. B. (2002). Neonatal development of the rat visual cortex: synaptic function of GABAA receptor α subunits. J. Physiol. 545, 169–181. doi: 10.1113/jphysiol.2002.026534
Caldji, C., Diorio, J., and Meaney, M. J. (2003). Variations in maternal care alter GABAA receptor subunit expression in brain regions associated with fear. Neuropsychopharmacology 28, 1950–1959. doi: 10.1038/sj.npp.1300237
Caldji, C., Tannenbaum, B., Sharma, S., Francis, D., Plotsky, P. M., and Meaney, M. J. (1998). Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat. Proc. Natl. Acad. Sci. U S A 95, 5335–5340. doi: 10.1073/pnas.95.9.5335
Castro, E., Oset-Gasque, M. J., and González, M. P. (1989). GABAA and GABAB receptors are functionally active in the regulation of catecholamine secretion by bovine chromaffin cells. J. Neurosci. Res. 23, 290–296. doi: 10.1002/jnr.490230307
Chen, J., Evans, A. N., Liu, Y., Honda, M., Saavedra, J. M., and Aguilera, G. (2012). Maternal deprivation in rats is associated with cortricotropin releasing hormone (CRH) promoter hypomethylation and enhances CRH transcriptional responses to stress in adulthood. J. Neuroendocrinol. 24, 1055–1064. doi: 10.1111/j.1365-2826.2012.02306.x
Corpéchot, C., Young, J., Calvel, M., Wehrey, C., Veltz, J. N., Touyer, G., et al. (1993). Neurosteroids: 3 α-hydroxy-5 α-pregnan-20-one and its precursors in the brain, plasma and steroidogenic glands of male and female rats. Endocrinology 133, 1003–1009. doi: 10.1210/en.133.3.1003
Coupland, R. E. (1975). “Blood supply of the adrenal gland,” in Handbook of Physiology Section 7 Endocrinology, Vol 6 Adrenal Gland, eds H. Blaschko, G. Sayers, and A. D. Smith (Washington, DC: American Physiological Society), 283–294.
Cutler, G. B. Jr., Glenn, M., Bush, M., Hodgen, G. D., Graham, C. E., and Loriaux, D. L. (1978). Adrenarche: a surey of rodents, domestic animals and primates. Endocrinology 103, 2112–2118. doi: 10.1210/endo-103-6-2112
Davis, J. P., Chipperfield, A. R., and Harper, A. A. (1993). Accumulation of intracellular chloride by (Na-K-Cl) co-transport in rat arterial smooth muscle is enhanced in deoxycorticosterone acetate (DOCA)/salt hypertension. J. Mol. Cell. Cardiol. 25, 233–237. doi: 10.1006/jmcc.1993.1029
Ding, B., Frisina, R. D., Zhu, X., Sakai, Y., Sokolowski, B., and Walton, J. P. (2014). Direct control of Na+–K+–2Cl––contransport protein (NKCC1) expression with aldosterone. Am. J. Physiol. Cell Physiol. 306, C66–C75. doi: 10.1152/ajpcell.00096.2013
Ehrlich, D. E., Ryan, S. J., Hazra, R., Guo, J. D., and Rainnie, D. G. (2013). Postnatal maturation of GABAergic transmission in the rat basolateral amygdala. J. Neurophysiol. 110, 926–941. doi: 10.1152/jn.01105.2012
Gammelsaeter, R., Frøyland, M., Aragón, C., Danbolt, N. C., Fortin, D., Storm-Mathisen, J., et al. (2004). Glycine, GABA and their transporters in pancreatic islets of langerhans: evidence for a paracrine transmitter interplay. J. Cell Sci. 117, 3749–3758. doi: 10.1242/jcs.01209
Genazzani, A. R., Petraglia, F., Bernardi, F., Casarosa, E., Salvestroni, C., Tonetti, A., et al. (1998). Circulating levels of allopregnanolone in humans: gender, age and endocrine influences. J. Clin. Endocrinol. Metab. 83, 2099–2103. doi: 10.1210/jc.83.6.2099
Geppert, M., Goda, Y., Hammer, R. E., Li, C., Rosahl, T. W., Stevens, C. F., et al. (1994). Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell 79, 717–727. doi: 10.1016/0092-8674(94)90556-8
Goto, J., Otsuka, F., Yamashita, M., Suzuki, J., Otani, H., Takahashi, H., et al. (2009). Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating rho and SAPK/JNK pathway in adrenomedullar cells. Am. J. Physiol. Endocrinol. Metab. 296, E904–E916. doi: 10.1152/ajpendo.90840.2008
Greif, K. F., Tillakaratne, N. J., Erlander, M. G., Feldblum, S., and Tobin, A. J. (1992). Transient increase in expression of a glutamate decarboxylase (GAD) mRNA during the postnatal development of the rat striatum. Dev. Biol. 153, 158–164. doi: 10.1016/0012-1606(92)90100-u
Hansen, S. L., Fjalland, B., and Jackson, M. B. (1999). Differential blockade of gamma-aminobutyric acid type A receptors by the neuroactive steroid dehydroepiandrosterone sulfate in posterior and intermediate pituitary. Mol. Pharmacol. 55, 489–496.
Harada, K., Matsuoka, H., Miyata, H., Matsui, M., and Inoue, M. (2015). Identification of muscarinic receptor subtypes involved in catecholamine secretion in adrenal medullary chromaffin cells by genetic deletion. Br. J. Pharmacol. 172, 1348–1359. doi: 10.1111/bph.13011
Harada, K., Matsuoka, H., Nakamura, J., Fukuda, M., and Inoue, M. (2010). Storage of GABA in chromaffin granules and not in synaptic-like microvesicles in rat adrenal medullary cells. J. Neurochem. 114, 617–626. doi: 10.1111/j.1471-4159.2010.06792.x
Hui, E., Bai, J., Wang, P., Sugimori, M., Llinas, R. R., and Chapman, E. R. (2005). Three distinct kinetic groupings of the synaptotagmin family: candidate sensors for rapid and delayed exocytosis. Proc. Natl. Acad. Sci. U S A 102, 5210–5214. doi: 10.1073/pnas.0500941102
Inoue, M., Harada, K., Nakamura, J., and Matsuoka, H. (2013). Regulation of alpha3-containing GABAA receptors in guinea-pig adrenal medullary cells by adrenal steroids. Neuroscience 253, 245–255. doi: 10.1016/j.neuroscience.2013.08.046
Inoue, M., Matsuo, T., and Ogata, N. (1985). Possible involvement of K+-conductance in the action of gamma-aminobutyric acid in the guinea-pig hippocampus. Br. J. Pharmacol. 86, 515–524. doi: 10.1111/j.1476-5381.1985.tb08923.x
Iwasa, K., Oomori, Y., and Tanaka, H. (1998). Gamma aminobutyric acid immunoreactivity in the mouse adrenal gland during postnatal development. Arch. Histol. Cytol. 61, 373–382. doi: 10.1679/aohc.61.373
Kaila, K., Price, T. J., Payne, J. A., Puskarjov, M., and Voipio, J. (2014). Cation-chloride contransporters in neuronal development, plasticity and disease. Nat. Rev. Neurosci. 15, 637–654. doi: 10.1038/nrn3819
Kajiwara, R., Sand, O., Kidokoro, Y., Barish, M. E., and Iijima, T. (1997). Functional organization of chromaffin cells and cholinergic synaptic transmission in rat adrenal medulla. Jpn. J. Physiol. 47, 449–464. doi: 10.2170/jjphysiol.47.449
Kanaani, J., Diacovo, M. J., El-Husseini, A.-D., Bredt, D. S., and Baekkeskov, S. (2004). Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5a-dependent pathway to presynaptic clusters. J. Cell Sci. 117, 2001–2013. doi: 10.1242/jcs.01030
Kataoka, Y., Fujimoto, M., Alho, H., Guidotti, A., Geffard, M., Kelly, G. D., et al. (1986). Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ. J. Pharmacol. Exp. Ther. 239, 584–590.
Kataoka, Y., Gutman, Y., Guidotti, A., Panula, P., Wroblewski, J., Cosenza-Murphy, D., et al. (1984). Intrinsic GABAergic system of adrenal chromaffin cells. Proc. Natl. Acad. Sci. U S A 81, 3218–3222. doi: 10.1073/pnas.81.10.3218
Le Goascogne, C., Sananès, N., Gouézou, M., Takemori, S., Kominami, S., Baulieu, E. E., et al. (1991). Immunoreactive cytochrome P-450(17 α) in rat and guinea-pig gonads, adrenal glands and brain. J. Reprod. Fertil. 93, 609–622. doi: 10.1530/jrf.0.0930609
Mahgoub, A., Hirsch, P. F., and Munson, P. L. (1997). Calcium-lowering action of glucocorticoids in adrenalectomized-prarathyroidectomized rats. Specificity and relative potency of natural and synthetic glucocorticoids. Endocine 6, 279–283. doi: 10.1007/bf02820504
Matsuoka, H., Harada, K., Endo, Y., Waraahina, A., Doi, Y., Nakamura, J., et al. (2008). Molecular mechanisms supporting a raracrinel role of GABA in rat adrenal medullary cells. J. Physiol. 586, 4825–4842. doi: 10.1113/jphysiol.2008.158709
Matsuoka, H., Harada, K., Nakamura, J., Fukuda, M., and Inoue, M. (2011). Differential distribution of synaptotagmin-1, -4, -7 and -9 in rat adrenal chromaffin cells. Cell Tissue Res. 344, 41–50. doi: 10.1007/s00441-011-1131-8
Minneci, F., Kanichay, R. T., and Silver, R. A. (2011). Estimation of the time course of neurotransmitter release at central synapses from the first latency of postsynaptic currents. J. Neurosci. Methods 205, 49–64. doi: 10.1016/j.jneumeth.2011.12.015
Mozrzymas, J. W., Barberis, A., and Vicini, S. (2007). GABAergic currents in RT and VB thalamic nuclei follow kinetic pattern of α3- and α1-subunit-containing GABAA receptors. Eur. J. Neurosci. 26, 657–665. doi: 10.1111/j.1460-9568.2007.05693.x
Navone, F., Jahn, R., Di Gioia, G., Stukenbrok, H., Greengard, P., and De Camilli, P. (1986). Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J. Cell Biol. 103, 2511–2527. doi: 10.1083/jcb.103.6.2511
Okada, M., Onodera, K., Van Renterghem, C., Sieghart, W., and Takahashi, T. (2000). Functional correlation of GABAA receptor α subunits expression with the properties of IPSCs in the developing thalamus. J. Neurosci. 20, 2202–2208.
Okada, Y., Taniguchi, H., and Schimada, C. (1976). High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma. Science 194, 620–622. doi: 10.1126/science.185693
Ortinski, P. I., Lu, C., Takagaki, K., Fu, Z., and Vicini, S. (2004). Expression of distrinct α subunits of GABAA receptor regulates inhibitory synaptic strength. J. Neurophysiol. 92, 1718–1727. doi: 10.1152/jn.00243.2004
Park-Chung, M., Malayev, A., Purdy, R. H., Gibbs, T. T., and Farb, D. H. (1999). Sulfated and unsulfated steroids modulate γ-aminobutyric acidA receptor function through distinct sites. Brain Res. 830, 72–87. doi: 10.1016/s0006-8993(99)01381-5
Peters, J. A., Lambert, J. J., and Cottrell, G. A. (1989). An electrophysiological investigation of the characteristics and function of GABAA receptors on bovine adrenomedullary chromaffin cells. Pflugers Arch. 415, 95–103. doi: 10.1007/bf00373146
Plattner, H., Artalejo, A. R., and Neher, E. (1997). Ultrastructural organization of bovine chromaffin cell cortex-analysis by cryofixation and morphometry of aspects pertinent to exocytosis. J. Cell Biol. 139, 1709–1717. doi: 10.1083/jcb.139.7.1709
Purdy, R. H., Morrow, A. L., Moore, P. H. Jr., and Paul, S. M. (1991). Stress-induced elevations of γ-induced elevations of aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. U S A 88, 4553–4557. doi: 10.1073/pnas.88.10.4553
Reetz, A., Solimena, M., Matteoli, M., Folli, F., Takei, K., and De Camilli, P. (1991). GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. Embo J. 10, 1275–1284.
Reul, J. M., de Kloet, E. R., van Sluijs, F. J., Rijnberk, A., and Rothuizen, J. (1990). Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology 127, 907–915. doi: 10.1210/endo-127-2-907
Rorsman, P., Berggren, P. O., Bokvist, K., Ericson, H., Möhler, H., Ostenson, C. G., et al. (1989). Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 341, 233–236. doi: 10.1038/341233a0
Sapolsky, R. M., and Meaney, M. J. (1986). Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res. 396, 64–76. doi: 10.1016/0165-0173(86)90010-x
Serafini, R., Maric, D., Maric, I., Ma, W., Fritschy, J. M., Zhang, L., et al. (1998). Dominant GABAA receptor/Cl- channel kinetics correlate with the relative expressions of α2, α3, α5 and β3 subunits in embryonic rat neurones. Eur. J. Neurosci. 10, 334–349. doi: 10.1046/j.1460-9568.1998.00022.x
Stork, O., Ji, F. Y., Kaneko, K., Stork, S., Yoshinobu, Y., Moriya, T., et al. (2000). Postnatal development of a GABA deficit and disturbance of neural functions in mice lacking GAD65. Brain Res. 865, 45–58. doi: 10.1016/s0006-8993(00)02206-x
Succol, F., Fiumelli, H., Benfenati, F., Cancedda, L., and Barberis, A. (2012). Intracellular chloride concentration influences the GABAA receptor subunit composition. Nat. Commun. 3:738. doi: 10.1038/ncomms1744
Ulmann, A., Bertagna, C., Le Go, A., Husson, J. M., Tache, A., Sassano, P., et al. (1985). Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism. Eur. J. Clin. Pharmacol. 28, 531–535. doi: 10.1007/bf00544063
Wang, P., Chicka, M. C., Bhalla, A., Richards, D. A., and Chapman, E. R. (2005). Synaptotagmin VII is targeted to secretory organelles in PC12 cells, where it functions as a high-affinity calcium sensor. Mol. Cell. Biol. 25, 8693–8702. doi: 10.1128/mcb.25.19.8693-8702.2005
Xie, Z., Currie, K. P., Cahill, A. L., and Fox, A. P. (2003). Role of cl- co-transporters in the excitation produced by GABAA receptors in juvenile bovine adrenal chromaffin cells. J. Neurophysiol. 90, 3828–3837. doi: 10.1152/jn.00617.2003
Xu, E., Kumar, M., Zhang, Y., Ju, W., Obata, T., Zhang, N., et al. (2006). Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab. 3, 47–58. doi: 10.1016/j.cmet.2005.11.015
Yokoi, H., Tsuruo, Y., Miyamoto, T., and Ishimura, K. (1998). Steroid 5 α-reductase type 1 immunolocalized in the adrenal gland of normal, gonadectomized and sex hormone-supplemented rats. Histochem. Cell Biol. 109, 127–134. doi: 10.1007/s004180050210
Keywords: GABA, adrenal chromaffin cell, PC12 cell, neuroactive steroid, paracrine, GAD67, GABAA receptors, immature subunit
Citation: Harada K, Matsuoka H, Fujihara H, Ueta Y, Yanagawa Y and Inoue M (2016) GABA Signaling and Neuroactive Steroids in Adrenal Medullary Chromaffin Cells. Front. Cell. Neurosci. 10:100. doi: 10.3389/fncel.2016.00100
Received: 04 June 2015; Accepted: 01 April 2016;
Published: 18 April 2016.
Edited by:Egidio D‘Angelo, University of Pavia, Italy
Reviewed by:Enrico Cherubini, International School for Advanced Studies, Italy
Andrea Barberis, Fondazione Istituto Italiano di Tecnologia, Italy
Copyright © 2016 Harada, Matsuoka, Fujihara, Ueta, Yanagawa and Inoue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Masumi Inoue, firstname.lastname@example.org